JPMorgan lowered the firm’s price target on Braskem (BAK) to $5 from $6 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAK:
- Braskem Continues Stake Sale Talks with Petroquímica Verde
- Braskem’s Credit Rating Downgraded by Fitch Amid Industry Challenges
- Braskem Initiates Asset Discussions with Unipar
- Braskem S.A. Reports Q2 2025 Financial Results
- Braskem S.A. Files Form 6-K with SEC Detailing Future Outlook Amid Challenges